These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9048275)

  • 1. Alterations in pharmacodynamics of anxiolytics in abstinent alcoholic men: subjective responses, abuse liability, and electroencephalographic effects of alprazolam, diazepam, and buspirone.
    Ciraulo DA; Barnhill JG; Ciraulo AM; Sarid-Segal O; Knapp C; Greenblatt DJ; Shader RI
    J Clin Pharmacol; 1997 Jan; 37(1):64-73. PubMed ID: 9048275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abuse liability and clinical pharmacokinetics of alprazolam in alcoholic men.
    Ciraulo DA; Barnhill JG; Greenblatt DJ; Shader RI; Ciraulo AM; Tarmey MF; Molloy MA; Foti ME
    J Clin Psychiatry; 1988 Sep; 49(9):333-7. PubMed ID: 3417618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacologic effects and abuse liability of bretazenil, diazepam, and alprazolam in humans.
    Busto U; Kaplan HL; Zawertailo L; Sellers EM
    Clin Pharmacol Ther; 1994 Apr; 55(4):451-63. PubMed ID: 8162672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of alprazolam and buspirone in light and moderate female social drinkers.
    Evans SM; Levin FR
    Behav Pharmacol; 2002 Sep; 13(5-6):427-39. PubMed ID: 12394419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection Times of Diazepam, Clonazepam, and Alprazolam in Oral Fluid Collected From Patients Admitted to Detoxification, After High and Repeated Drug Intake.
    Nordal K; Øiestad EL; Enger A; Christophersen AS; Vindenes V
    Ther Drug Monit; 2015 Aug; 37(4):451-60. PubMed ID: 25549207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review of the side-effect profile of buspirone.
    Newton RE; Marunycz JD; Alderdice MT; Napoliello MJ
    Am J Med; 1986 Mar; 80(3B):17-21. PubMed ID: 2870641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of the abuse liability of alprazolam, lorazepam, diazepam, methaqualone, and placebo.
    Orzack MH; Friedman L; Dessain E; Bird M; Beake B; McEachern J; Cole JO
    Int J Addict; 1988 May; 23(5):449-67. PubMed ID: 3061941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liability to alprazolam abuse in daughters of alcoholics.
    Ciraulo DA; Sarid-Segal O; Knapp C; Ciraulo AM; Greenblatt DJ; Shader RI
    Am J Psychiatry; 1996 Jul; 153(7):956-8. PubMed ID: 8659624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the abuse liability of buspirone in recreational sedative users.
    Cole JO; Orzack MH; Beake B; Bird M; Bar-Tal Y
    J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):69-75. PubMed ID: 6130076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tandospirone and alprazolam: comparison of behavioral effects and abuse liability in humans.
    Evans SM; Troisi JR; Griffiths RR
    J Pharmacol Exp Ther; 1994 Nov; 271(2):683-94. PubMed ID: 7965783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alprazolam and diazepam: addiction potential.
    Juergens S
    J Subst Abuse Treat; 1991; 8(1-2):43-51. PubMed ID: 2051498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased sensitivity to alprazolam in females with a paternal history of alcoholism.
    Evans SM; Levin FR; Fischman MW
    Psychopharmacology (Berl); 2000 Jun; 150(2):150-62. PubMed ID: 10907668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alprazolam absorption kinetics affects abuse liability.
    Mumford GK; Evans SM; Fleishaker JC; Griffiths RR
    Clin Pharmacol Ther; 1995 Mar; 57(3):356-65. PubMed ID: 7697954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preference for alprazolam as opposed to diazepam in benzodiazepine-dependent psychiatric inpatients.
    Apelt S; Schmauss C; Emrich HM
    Pharmacopsychiatry; 1990 Mar; 23(2):70-5. PubMed ID: 1971118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of the abuse liability of buspirone in alcohol-dependent patients.
    Griffith JD; Jasinski DR; Casten GP; McKinney GR
    Am J Med; 1986 Mar; 80(3B):30-5. PubMed ID: 3963032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of suicide attempts and intentional self-harm on alprazolam.
    Gibbons RD; Hur K; Lavigne JE; Mann JJ
    Psychiatry Res; 2024 May; 335():115857. PubMed ID: 38493738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of interaction between disulfiram and alprazolam in alcoholic patients.
    Diquet B; Gujadhur L; Lamiable D; Warot D; Hayoun H; Choisy H
    Eur J Clin Pharmacol; 1990; 38(2):157-60. PubMed ID: 2338112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of pharmacokinetic interaction between buspirone and alprazolam at steady state.
    Buch AB; Van Harken DR; Seidehamel RJ; Barbhaiya RH
    J Clin Pharmacol; 1993 Nov; 33(11):1104-9. PubMed ID: 8300893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and CNS pharmacodynamics of the 5-HT1A agonist buspirone in humans following acute L-tryptophan depletion challenge.
    Jagannathan V; Venitz J
    Methods Find Exp Clin Pharmacol; 1997 Jun; 19(5):351-62. PubMed ID: 9379784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discriminative stimulus effects of alprazolam and diazepam: generalization to benzodiazepines, antidepressants and buspirone.
    Wettstein JG; Gauthier B
    Behav Pharmacol; 1992 Jun; 3(3):229-237. PubMed ID: 11224120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.